SCHEMBL1095503

SCHEMBL1095503

Nc1nc(O)[nH]c(=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31495236 0.74
SCHEMBL36982 0.74
SCHEMBL5320771 0.72 L3MBTL1 (0.50)
SCHEMBL28484406 0.72 L3MBTL1 (0.50)
SCHEMBL22516444 0.70
SCHEMBL1096504 0.70
Thiourea SCHEMBL9245207 0.70 L3MBTL1 (0.44)
SCHEMBL7113565 0.67 PNP (0.36)
SCHEMBL10481673 0.65 L3MBTL1 (0.44)
SCHEMBL796035 0.65 L3MBTL1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153787-B2 Azacytosine derivatives useful as antiviral agents K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2012-04-10 US disclosed
EP-1966226-B1 AZACYTOSINE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS LEUVEN K U RES & DEV (BE) 2010-11-10 EP disclosed
WO-2009139888-A1 ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF CELGENE CORPORATION (US) 2009-11-19 WO disclosed
US-20090005346-A1 Azacytosine Derivatives Useful as Antiviral Agents K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2009-01-01 US disclosed
EP-1966226-A2 AZACYTOSINE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS K.U.Leuven Research &amp; Development (BE) 2008-09-10 EP disclosed
WO-2007065231-A2 AZACYTOSINE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2007-06-14 WO disclosed